Denintuzumab (Anti-CD19)
Denintuzumab (anti-CD19) is a recombinant humanized anti-CD19 monoclonal antibody that can be used in the research of acute lymphoblastic leukemia. Denintuzumab can be used to synthesize ADC antibody Denintuzumab Mafodotin (SGN-CD19A). MW: 145.0 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2795 |
| Sku # | A2795-1mg*5 |
| Pricing | 1mg*5, $970.00 |